Boumediene K, Vivien D, Macro M, Bogdanowicz P, Lebrun E, Pujol J P
Laboratoire de Biochimie du Tissu Conjonctif CJF INSERM Caen, France.
Cell Prolif. 1995 Apr;28(4):221-34. doi: 10.1111/j.1365-2184.1995.tb00065.x.
We have previously shown that TGF-beta 1 exerts a bifunctional effect on RAC proliferation. Added to quiescent cultures, it inhibits the entry of G0/G1 cells into S phase whereas in S phase synchronized populations, it stimulates the DNA replication rate with a delayed G2 + M phase and a subsequent transient increase of cell number. As TGF-beta 2 and beta 3 isoforms are also expressed in bone and cartilage tissues, it was of interest to study their effect on RAC proliferation, in comparison to that of TGF-beta 1. Using cell counting and tritiated thymidine incorporation, we found that all the TGF-beta s used here induced an increase of RAC proliferation rate occurring between 24 and 48 h of exposure. TGF-beta 2 appeared as the most efficient form as judged from the maximum of thymidine labelling. However, TGF-beta 3 induced an increase of cell number slightly higher than both TGF-beta 1 and TGF-beta 2 (+30% versus 20% for TGF-beta 1 and beta 2). TGF-beta 2 and beta 3 were able to stimulate the DNA replication rate as previously demonstrated for TGF-beta 1. However, the effect occurred later for TGF-beta 2 and beta 3 (12 h) than for TGF-beta 1 (6 h). This was confirmed by flow cytometric analysis of DNA content. In addition, immunodetection by flow cytometry demonstrated that all TGF-beta isoforms enhanced endogenous expression of TGF-beta-related peptides. The effect was shown to be associated with the cell cycle S phase and was greater for TGF-beta 3 than for TGF-beta 1 and beta 2. These findings suggest that TGF-beta s could act on RAC functions via autocrine and paracrine ways. Taken together, these data indicate that TGF-beta s may modulate proliferation of articular chondrocytes and therefore could play a role in the activation of these cells in the early stages of osteoarthritis.
我们之前已经表明,转化生长因子β1(TGF-β 1)对RAC增殖具有双功能作用。添加到静止培养物中时,它会抑制G0/G1期细胞进入S期;而在S期同步化的细胞群体中,它会刺激DNA复制速率,使G2 + M期延迟,并随后使细胞数量短暂增加。由于TGF-β 2和β 3亚型也在骨和软骨组织中表达,因此,与TGF-β 1相比,研究它们对RAC增殖的影响很有意义。通过细胞计数和氚标记胸腺嘧啶核苷掺入实验,我们发现,这里使用所有TGF-β 均在暴露24至48小时之间诱导RAC增殖速率增加。从胸腺嘧啶核苷标记的最大值判断,TGF-β 2似乎是最有效的形式。然而,TGF-β 3诱导的细胞数量增加略高于TGF-β 1和TGF-β 2(分别为+30%,而TGF-β 1和β 2为20%)。TGF-β 2和β 3能够像之前证明的TGF-β 1那样刺激DNA复制速率。然而,TGF-β 2和β 3的作用(12小时)比TGF-β 1(6小时)出现得更晚。这通过DNA含量的流式细胞术分析得到证实。此外,流式细胞术免疫检测表明,所有TGF-β 亚型均增强了TGF-β 相关肽的内源性表达。该作用被证明与细胞周期S期相关,且TGF-β 3的作用大于TGF-β 1和β 2。这些发现表明,TGF-β 可能通过自分泌和旁分泌方式作用于RAC功能。综上所述,这些数据表明,TGF-β 可能调节关节软骨细胞的增殖,因此可能在骨关节炎早期阶段这些细胞的激活中发挥作用。